The landscape of obesity treatment is rapidly evolving with the emergence of several innovative injectable therapies. the GLP-1/GIP dual agonist, a peptide with multiple actions, Survodutide , and a GLP-1 https://nexaphresearchpeptides.com/product-category/anti-aging-peptides/